DEA safety
This article was originally published in The Rose Sheet
Executive Summary
NTP report on diethanolamine finding "clear carcinogenic activity" is insufficient evidence to support listing under California Prop 65, CTFA Director-Safety and Regulatory Toxicology Linda Loretz maintains at the association's Science Executive Leadership Conference Oct. 29-31 in Washington, D.C. DEA does not meet the standard for causing cancer, Loretz claims. California's Office of Environmental Health Hazard Assessment determined sufficient criteria for listing DEA after reviewing CTFA's April 1999 comments opposing the listing (1"The Rose Sheet" April 26, 1999, p. 11). FDA did not meet its Oct. 1 deadline to complete DEA risk assessment, and will address the issue by the end of fiscal year 2001, Office of Cosmetics & Colors Acting Director Adele Dennis says at CTFA conference
You may also be interested in...
Diethanolamine Should Not Make Prop 65 List While Under FDA Review - CTFA
A safety ruling on diethanolamine by California EPA's Office of Environmental Health Hazard Assessment (OEHHA) would be "premature" while the cosmetic and OTC drug ingredient is undergoing FDA review, the Cosmetic, Toiletry and Fragrance Association asserts in April 6 comments to the agency.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle